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The effect of HIV prevention products on incentives to supply condomless commercial sex 
amongst female sex workers in South Africa 
Abstract 
Evidence suggests that economic factors play an important role in commercial sex work, in 
particular that condomless sex commands a price premium relative to condom protected sex. 
This paper explores whether the use of a new HIV prevention product, with 100% efficacy but 
modelled after pre-exposure prophylaxis (PrEP), could change the price and quantity of 
condomless commercial sex supplied. We collected stated preference data from 122 HIV negative 
female sex workers (FSWs) in urban South Africa, using a repeated choice experiment to simulate 
the impact of using PrEP on choices. Results suggest that the price premium for condomless sex 
would decrease by 73% with PrEP use (described as 100% effective in preventing HIV), and the 
quantity of condomless sex is predicted to increase by a factor of 2.27. Act price does not 
significantly affect choices without protection, but strongly influences choices under full HIV 
protection. The utility offered by condoms reduces by around 15% under PrEP use. Because new 
HIV prevention products do not protect against other STIs or pregnancy, the unintended 
consequences of introducing HIV prevention products should be closely monitored, whilst users 
should not face stigma or blame for reacting rationally to exogenous changes to market 
conditions. 
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Introduction 
Women engaged in commercial sex, or female sex workers (FSWs), face daily risks of HIV 
acquisition [1], not least in urban South Africa where HIV prevalence among FSWs is estimated 
to be as high as 72% in some cities [2]. FSWs face different choices and incentives from other 
high-risk populations, because, in addition to navigating the complexities of sexual and personal 
risk in non-commercial sexual relationships, economic and social inequalities mean that FSWs 
often face strong competition from FSW colleagues, client resistance to condom use, and threats 
and use of violence from clients and police [3-6]. A growing topic for economic research, analyses 
have sought to explain entry into and persistence of the industry [7-9], the intensive margin of 
risk/benefit trade-offs [10, 11], and vulnerabilities faced by FSWs from broader economic forces 
[12, 13]. 
Financial incentives in sex work may directly affect the HIV, STI, and pregnancy risk FSWs bear. 
For example, econometric work has estimated a price premium for condomless sex relative to 
protected sex, referred in the literature as the condom differential. Anecdotal evidence of a 
differential (e.g. [6]) was first empirically estimated by Rao [10] who found that Indian FSWs who 
used condoms consistently faced income losses of up to 79%, whilst further econometric 
evidence has estimated price premia in different contexts  between 7% (Belgium and the 
Netherlands) to 81% (Bangladesh) [10-12, 14-17]. In many circumstances, FSWs are highly 
dependent on sex work to support themselves and their families [18], and therefore may be at 
heightened risk when offered more money for unprotected sex. 
The HIV prevention landscape has evolved considerably in recent years, not least due to emerging 
evidence that antiretroviral (ARV) drugs can be used for HIV prevention. The HPTN 052 trial 
demonstrated the ability of ARVs to reduce the infectiousness of HIV-positive persons through 
suppressing viral loads [19], and has led to the development of pre-exposure prophylaxis (PrEP) 
which has shown to offer a high degree of protection when used by HIV-negative persons in 
different contexts and populations worldwide [20]. In 2012, the World Health Organisation 
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(WHO) recommended oral PrEP to be used in groups at high risk of HIV acquisition [21]. By 
implementing national guidelines for the provision of PrEP among FSWs in 2016, South Africa 
became one of the first countries worldwide to offer ARV-based prevention to any group [22]. In 
such early stages of PrEP distribution, it is critical that we fully understand the impact that PrEP 
might have on potential users, specifically to understand potential unintended consequences 
associated with sustained PrEP use which, to-date, clinical trials have not considered. 
We hypothesise that the introduction of a fully effective HIV prevention product will affect both 
the supply and demand of protected and condomless sex because an HIV negative user will bear 
less risk from engaging in condomless sex. Henceforth, when we refer to PrEP in this paper, we 
define it as a fully effective HIV prevention product. Using the theory of compensating 
differentials, we show that this would result in both a) an increase in the quantity of condomless 
sex supplied, and b) a decrease in the price premium for condomless sex, under reasonable 
assumptions. To test this empirically, we interviewed 203 FSWs in Ekurhuleni Municipality, in 
the urban periphery of Johannesburg, South Africa.  
An ideal study design to test this hypothesis would be to randomly allocate a group of FSWs to 
receive an actual PrEP product, with associated efficacy and attributions, and a group to receive 
nothing, comparing changes in pricing and the supply of protected and unprotected acts. 
However, this randomisation was not practically or ethically possible, largely because of PrEP’s 
proven efficacy, whilst we were not able to access the small number of FSWs using PrEP in South 
Africa when this study was conducted; we therefore take a different approach.  
We used stated preference methods, a repeated discrete choice experiment (DCE) presented with 
and without framing of HIV protection, to estimate the effect of hypothetical PrEP use on FSW 
preferences for condom, price, and client characteristics. In addition to overcoming the issues 
above, this within-participant design also avoids issues of potential endogeneity from selection 
into a PrEP programme. Stated preference methods are used frequently in health [23], transport 
[24, 25] and environmental economics [26], offering a flexible and theoretically robust approach 
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to eliciting preferences towards products and situations that do not yet exist [27]. Although their 
hypothetical nature means that stated and revealed preferences may not be perfectly concordant, 
empirical research in health has shown relatively small levels of hypothetical bias and reasonable 
external validity [28-30]. From the DCE, we find that PrEP use will reduce the price premium for 
condomless sex by 73%, and simulations indicate that the quantity of condomless sex supplied 
will more than double. When asked to respond as if using a 100% effective HIV prevention 
product, the utility provided by condom use was diminished by 15%. We find that FSWs do not 
make choices based on price at present, however the price paid by a client would strongly 
influences choice under full HIV protection. 
This paper makes two contributions to the economic literature on sex work and HIV prevention, 
and provides new insights into a critical population in the country with the world’s largest HIV 
burden. First, to-date a body of economic work exists which explores the nature and challenges 
of sex work, yet no research has looked at the potential impact of new PrEP products on the 
incentives, risks and pressures that FSWs face. Secondly, despite a high estimated prevalence 
among a national population of 130,000 FSWs [31], to-date this is the only published piece of 
economic work among South African FSWs.  
Theoretical model of commercial sex 
The following model is an extension of that devised by Gertler, Shah and Bertozzi [11], the first 
paper to formalise the FSW/client relationship in a partial equilibrium framework. First, we 
describe their model which considers the market where condoms are the only way of preventing 
HIV transmission, before extending it to consider the effect of a new prevention product.  
FSW and client utility payoffs 
Take a client's willingness to pay (utility) for sex to be V, whilst his maximum willingness to pay 
to not use a condom (disutility) is 𝛽. Then: 
𝑌𝑐𝑜𝑛𝑑𝑜𝑚
𝑐𝑙𝑖𝑒𝑛𝑡 = 𝑉 − 𝛽 − 𝑃𝑐  
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Where 𝑌𝑐𝑜𝑛𝑑𝑜𝑚
𝑐𝑙𝑖𝑒𝑛𝑡  is a client's utility payoff from condom protected sex with a FSW, and 𝑃𝑐  the price 
he pays her for protected sex. Considering his utility payoff from unprotected sex, the 𝛽 element 
is dropped and his payoff function becomes: 
𝑌𝑛𝑜𝑐𝑜𝑛𝑑𝑜𝑚
𝑐𝑙𝑖𝑒𝑛𝑡 = 𝑉 − 𝑃𝑛𝑐 
Where 𝑌𝑛𝑜𝑐𝑜𝑛𝑑𝑜𝑚
𝑐𝑙𝑖𝑒𝑛𝑡  is a client's utility payoff from unprotected sex with a FSW, and 𝑃𝑛𝑐 is the price 
he pays her for unprotected sex.  
The utility payoffs for FSWs are: 
𝑌𝑐𝑜𝑛𝑑𝑜𝑚
𝐹𝑆𝑊 = 𝑃𝑐 − 𝑊 
And: 
𝑌𝑛𝑜𝑐𝑜𝑛𝑑𝑜𝑚
𝐹𝑆𝑊 = 𝑃𝑛𝑐 − 𝛾 − 𝑊 
Thus the FSW gains utility from the amount a client pays. However, when she engages in 
unprotected sex, she suffers a disutility from exposing herself to risk, discomfort, or other 
negative attributes of unprotected sex. Furthermore, the sex-worker can expect to receive W from 
the next-best use of her time.  
We assume that clients and FSWs have a choice whether to engage in any type of sex, though allow 
for differences in bargaining power between the two groups. The model suggests that a FSW will 
supply unprotected sex if both she and the client agree not to use a condom. For FSWs, this will 
occur when the marginal revenue she receives from unprotected sex (𝑃𝑛𝑐 − 𝑃𝑐) is greater than 
or equal to her disutility from not using a condom (𝛾) . For clients, this will occur when his 
marginal cost of not using a condom (𝑃𝑛𝑐 − 𝑃𝑐) is less than his disutility from condom use (𝛽). 
Therefore, two conditions must hold for unprotected sex to occur: 
𝛽 > 𝛾 
And: 
6 
 
𝑉 > (𝑊 + 𝛾) 
In other words, that the maximum a client is willing to pay not to use a condom is greater than 
the maximum a FSW is willing to accept to take the risk; and that the client's maximum 
willingness to pay for sex is greater than a FSW's costs associated in non-condom sex.  
We consider the effect of PrEP on client and FSW payoffs. First, we assume that the FSW's 
disutility from supplying unprotected sex declines. We define a new parameter,𝜂, that represents 
this change, so that her payoff from non-condom use is now:  
𝑌𝑛𝑜𝑐𝑜𝑛𝑑𝑜𝑚
𝐹𝑆𝑊 = 𝑃𝑛𝑐 − (𝛾 − 𝜂) − 𝑊 
where 𝜂  is assumed to be positive. Similarly, we assume that male clients' utility from non-
condom sex increases by the extent to which a client values HIV protection (which is now 
provided by PrEP). We represent the clients' utility gain from PrEP by 𝜉 so that his payoff from 
non-condom use is now: 
𝑌𝑛𝑜𝑐𝑜𝑛𝑑𝑜𝑚
𝑐𝑙𝑖𝑒𝑛𝑡 = 𝑉 + 𝜉 − 𝑃𝑛𝑐 
where, again, 𝜉 is assumed to be positive. Payoffs from condom use have not changed, so we retain 
the equilibrium price of unprotected sex from Gertler, Shah, and Bertozzi[11]: 
𝑃𝐶 = (1 − 𝛼)(𝑉 − 𝛽) + 𝛼𝑊 
To find the new equilibrium price for non-condom use with PrEP, we maximise: (𝑉 + 𝜉 −
𝑃𝑛𝑐)𝛼(𝑃𝑛𝑐 − (𝛾 − 𝜂) − 𝑊)(1−𝛼)  where 𝛼  represents the client’s bargaining power, and (1- 𝛼  ) 
FSW bargaining power. We obtain: 
𝑃𝑛𝑐 = (1 − 𝛼)(𝑉 + 𝜉) + 𝛼(𝛾 − 𝜂 + 𝑊) 
Then, by subtracting 𝑃𝑛𝑐 − 𝑃𝑐 , we obtain the price differential between protected and 
unprotected sex: 
𝑃𝑛𝑐 − 𝑃𝑐 = (1 − 𝛼)(𝛽 + 𝜉) + 𝛼(𝛾 − 𝜂) 
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We can then compare the price premium for non-condom use with PrEP tp that without PrEP: 
𝑃𝑟𝑒𝑚𝑃𝑟𝐸𝑃 − 𝑃𝑟𝑒𝑚𝑂𝑟𝑖𝑔 = (1 − 𝛼)𝜉 − 𝛼𝜂 
The impact of PrEP on the price premium for non-condom use therefore depends on the relative 
bargaining weights of the FSW and client, and the amount of utility the client and the sex worker 
each gain through the use of PrEP. The premium will decline if the following condition holds: 
1 − 𝛼
𝛼
<
𝜂
𝜉
  
(1) 
 Note that since both 𝜂 and 𝜉 are assumed positive, the following pair of assumptions generate a 
decline in the price premium under PrEP: 
(i) The client’s bargaining power is greater than the FSW’s: 𝛼 > 1 − 𝛼 
(ii) The FSW gains more utility from PrEP than the client: 𝜂 > ξ 
Under these two assumptions, which we believe are reasonable, the left hand side of condition 
(1) is less than 1, whilst the right hand side is greater than 1, so the inequality is always satisfied. 
Empirical methods 
Study overview 
The DCE was designed to elicit FSW preferences towards clients and sex act characteristics. To 
estimate the impact of PrEP on choices, the same ten DCE tasks were presented twice to HIV 
negative FSWs, firstly with no framing: “You have the choice between providing services to one of 
two clients. Which would you prefer?” prior to a comprehensive description of a range of potential 
PrEP products to respondents. Then, the choice tasks were presented again with a protected 
framing: “Now I would like you to choose between 10 more sets of clients, but this time I would like 
you to make your choices imagining you were using a product which prevented you from getting 
infected with HIV. This means that there would be no risk of getting HIV from any client, whether or 
not you use a condom. Which would you prefer?” 
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Because respondents answered the same choice tasks twice (with different frames), we were able 
to test whether different choice task framings had a causal impact on FSW choices. Interviewers 
were experienced in sexual history surveying, and were thoroughly trained and tested on their 
explanation of products and the DCE. Example products (an oral tablet, an injectable, a 
microbicide gel, and a intravaginal ring) were given to respondents to examine in an effort to 
imagine real-life use, and interviewers answered any questions they had. In an additional DCE, 
preferences for product characteristics were consistent with prior expectations, demonstrating 
participant understanding of the protective benefits of products [32, 33].  
A respondent-driven sampling (RDS) method [34] was used to recruit 203 FSWs in Ekurhuleni 
Municipality, Gauteng Province. Peer educators were used to locate sex work hotspots and 12 
were asked to act as seeds to start RDS chains in different areas (i.e. women working in brothels, 
hotels or on the street). Seeds were invited to complete the survey and received ZAR 50 (USD 
$3.50) compensation for their time before they were given four coupons containing study 
information to distribute to other FSWs. When each referred FSW attended for an interview, their 
peer recruiter received a small incentive in the form of a ZAR 20 (USD $1.40) voucher.  
The study was reviewed and approved by the University of the Witwatersrand Human Research 
Ethics Committee (HREC) and the Research Ethics Committee at the London School of Hygiene 
and Tropical Medicine. All participation in the DCE, alongside supporting qualitative studies, was 
voluntary and subject to completion of written informed consent. The background survey asked 
several questions which led to a number of disclosures of distressing events, and a 
comprehensive distress protocol ensured that participants who disclosed these were referred to 
named persons at local clinics and NGOs. 
Questionnaire 
Selection of attributes and levels 
The development of the DCE tasks was primarily based on thematic analysis of four focus group 
discussions. These were carried out with 52 self-reported active FSW participants recruited 
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through convenience sampling, with the assistance of FSW peer-educators through a local non-
governmental organisation. Qualitative analysis (presented elsewhere [35]) generated a long list 
of potential DCE attributes, supplemented by key themes emerging from a scoping literature 
review. Final attributes and pictorial representations of choice tasks were then chosen through 
discussions with FSWs, peer educators, the FSW community advisory board at the Wits 
Reproductive Health and HIV Institute, and input from UK and South African experts in DCE 
methods.  
Table 1 presents the final list of attributes and their levels, alongside the hypothesised direction 
of impact for each (positive or negative impact on utility). For example, we expect act price to 
have a positive coefficient and increase utility, whilst providing services to clients perceived to 
have an STI or HIV is likely to have a negative coefficient as it reduces utility. Figure 1 gives an 
example of a choice task as presented to respondents. The rest of the questionnaire captured data 
on a range of factors which may influence risk and pricing decisions such as socio-economic 
characteristics, commercial and non-commercial sexual history, and exposure to structural 
factors such as intimate partner violence; these are used to explore preference heterogeneity 
though interaction terms.  
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Table 1: Attributes and levels 
Attribute Levels Hypothesised 
coefficient 
sign  
Price for sex R100 (US $7.03), R200 (US $14.06), R400 (US 
$28.12), R800 (US $56.24) 
+ 
Condom use Condom, no condom +,- 
Type of sex Vaginal sex, anal sex +,- 
Perceived client HIV 
risk 
“You think this client has HIV”, “You don't think this 
client has HIV” 
-,+ 
Perceived client STI 
risk 
“You think this client has an STI”, “You don't think 
this client has an STI” 
-,+ 
Task frame No framing: “You have the choice between providing 
services to one of two clients. Which would you prefer?” 
 
PrEP framing: “Now I would like you to choose 
between 10 more sets of clients, but this time I would 
like you to make your choices imagining you were 
using a product which prevented you from getting 
infected with HIV. This means that there would be no 
risk of getting HIV from any client, whether or not you 
use a condom. Which would you prefer?” 
 
 
  
11 
 
Figure 1: Example choice task without PrEP framing 
 
Experimental design 
We apply best-practice DCE design methods and use a fractional factorial design to generate the 
experimental design used in piloting, with pilot data subsequently providing Bayesian priors for 
the final design [27]. A 10-taask, D-efficient unlabelled design was generated using NGENE 
software [36] with four unconstrained binary attributes (condom, sex, HIV risk, STI risk) and one 
continuous linear attribute (price). Discussion continues in the literature on the best way to 
create efficient DCE designs e.g., however, D-efficient designs are increasingly popular due to 
computational efficiency and statistical performance [23, 37-39].  
Analysis 
Multinomial logit (MNL) estimation 
Random utility models are used extensively in choice modelling, with the majority of health 
applications based on the multinomial logit (MNL) model [23, 40]. The MNL is computationally 
easy to implement, however, requires stringent assumptions including the absence of taste 
heterogeneity across respondents alongside restrictive patterns of substitution across 
alternatives. Nevertheless, the MNL is a useful model with which to explore choice patterns in the 
data before moving to more advanced estimation methods [27].  
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Thus, the utility of respondent n for alternative i is given by a deterministic and measurable 
element 𝑉𝑛,𝑖  and a stochastic, unobserved element 𝜀𝑛,𝑖: 
𝑈𝑛,𝑖 = 𝑉𝑛,𝑖 + 𝜀𝑛,𝑖 (1) 
Assuming that 𝜀𝑛,𝑖 has a type I extreme value distribution with values independently and 
identically distributed, the probability of choosing alternative i from choice set j is given by: 
𝑃𝑛,𝑖 =
𝑒𝑉𝑛,𝑖
∑ 𝑒𝑉𝑛,𝑖𝐽𝑗=1
 
(2) 
The MNL model is estimated by defining 𝑉𝑛,𝑖 as a vector of explanatory variables from the DCE 
design 𝑋𝑛,𝑖
′ 𝛽𝑖 and maximising a log-likelihood function in relation to 𝛽. 
Mixed multinomial logit (MMNL) estimation 
As described by Hess et al. [41], we estimate a mixed multinomial logit (MMNL) where the 
parameter vector 𝛽 is assumed to be randomly distributed rather than fixed, such that 𝛽~𝑓(𝛽, Ω): 
𝑃𝑛,𝑖 = ∫ 𝑃𝑛,𝑖
 
𝛽
(𝛽, 𝑥𝑛,𝑖)𝑓(𝛽, Ω)𝑑𝛽 
(3) 
Where Ω is a parameter vector of the distribution of the elements contained in 𝛽.  
A restriction of the MMNL model is that the analyst needs to specify which parameters are 
randomly distributed across agents, as well as the way they are distributed (i.e. according to a 
normal, lognormal, or uniform distribution). The requirement of these assumptions is generally 
seen as a small cost for the ability of MMNL specifications to allow for taste heterogeneity, where 
preferences are allowed to vary across individuals [27, 41].  
To test the effect of the DCE framing we define 𝛽𝑛,𝑖 to include  
𝛽𝑛,𝑖 = 𝛼𝑛 + 𝛿𝑛 ∗ 𝑃𝑟𝐸𝑃_𝐹𝑟𝑎𝑚𝑒𝑛  (4) 
Where 𝛼𝑛 is a coefficient vector capturing preferences with no framing, 𝑃𝑟𝐸𝑃_𝐹𝑟𝑎𝑚𝑒 a binary 
variable equal to 1 when the PrEP framed DCE is being presented, and 𝛿𝑛  a coefficient vector 
capturing deviations between the two framings. We calculate robust t-ratios to test the 
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divergence of 𝛿  elements from zero. All parameters are estimated as random and normally 
distributed in MMNL estimation to reflect uncertainty in the distribution of their variance, and 
1000 Halton draws are created to estimate the model. 
Willingness to accept condomless sex 
Analogous to willingness to pay estimates in the literature, we compute the relative importance 
of sex-act attributes in monetary terms. For example, assuming a utility function which is linear 
in parameters, the willingness to accept (WTA) condomless sex can be expressed as the monetary 
value: 
𝑤𝑘 =  
𝛽𝑘
𝛽𝑐
 
(5) 
Where 𝛽𝑘  is the parameter for condom use, and 𝛽𝑐  the price parameter. Because 𝛽𝑘  and 𝛽𝑐  are 
estimated with uncertainty, we consider the extent to which 𝑤𝑘  is uncertain using the Delta 
method to estimate the standard error of 𝑤𝑘. Assuming that ?̂? is asymptotically distributed such 
that 𝛽?̂?
𝐷
→ 𝑁(𝛽, Ω𝛽), then, as shown in in Bliemer and Rose [42], the asymptotic standard error of 
𝑤𝑘 is: 
𝑠𝑒(𝑤𝑘 )̂ =  
1
𝛽𝑐
√𝑣𝑎𝑟(𝛽𝑘) − 2𝑤𝑘𝑐𝑜𝑣(𝛽𝑘 , 𝛽𝑐) + 𝑤𝑘
2𝑣𝑎𝑟(𝛽𝑐) 
(6) 
We use the Delta method to assess the significance of the ratio of condom use and price 
parameters (the condom differential) in the unframed DCE, the PrEP framed DCE, and to test 
whether the ratio 𝑧𝑘 is significantly different from zero: 
𝑧𝑘 =
𝛽𝑘
𝑝𝑟𝑒𝑝/𝛽𝑐
𝑝𝑟𝑒𝑝
𝛽𝑘
𝑛𝑜𝑝𝑟𝑒𝑝/𝛽𝑐
𝑛𝑜𝑝𝑟𝑒𝑝 
(7) 
Simulations of behaviour change 
We apply predicted probability analysis (PPA) to simulate the impact of PrEP on the price and 
supply of protected and condomless sex. As elsewhere in the health literature [27, 43, 44], we 
predict the supply response to PrEP introduction by summing the model coefficients with 
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imputed attribute levels. As best-practice in WTP studies from DCE data, we rescale results for 
simulation using revealed preference data. We take the absolute price premium as self-reported 
by FSWs, and reduce it by the factor 𝑧𝑘 to generate the new price of condomless sex. We hold all 
attributes except condom use and price constant across framings, and use MNL model outputs for 
transparency in simulations, simply substituting 𝑉𝑛,𝑖  into equation (2). 
Results 
Characteristics of respondents 
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Table 2 displays the descriptive statistics from the sample. In total 203 FSWs were interviewed, 
of whom 81 (40%) self-reported as being HIV positive. The remaining 122 HIV negative 
respondents completed both DCEs (thus acting as their own counterfactual), and we restrict 
analysis to this group. Each DCE had ten choice tasks, meaning that we had 20 observations per 
respondent (10 without PrEP, and 10 with PrEP) resulting in 2,440 choice data points. The 
average age of HIV negative respondents (29.48) was significantly (p>0.01) lower than HIV 
positive respondents (32.95) and they were significantly less likely to have children (p>0.01). In 
addition, HIV negative FSWs were more likely to make all their income from sex work (p>0.01), 
and to have earned more from sex work in the last week (p=0.05). The marriage rate was 
noticeably low in this sample at 2% for both HIV positive and negative respondents, though 65% 
reported being in a relationship. Whilst reported rates of consistent condom use (“always”) with 
commercial partners are much higher than other FSW surveys in South Africa [2]. Interestingly, 
HIV positive FSWs report charging significantly more than HIV negative FSWs (p=0.04) for 
protected sex, whilst there is no significant difference for condomless acts. The price premium for 
unprotected sex among HIV negative FSWs is 1.8 times greater than that of HIV positive sex 
workers, though this difference is not statistically significant (p=0.14). 
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Table 2: Descriptive Statistics 
Variable 
Whole 
sample %/(SD) 
HIV 
Negative 
(n=122) %/(SD) 
HIV 
Positive 
(n=81) %/(SD) 
Difference 
between HIV 
positive and 
negative:  
t-test p-value 
Age 30.87 (6.17) 29.48 (5.72) 32.95 (6.27) >0.01 
Secondary 
education 155 76% 96.38 79% 59.13 73% 0.44 
Married 4.06 2% 2.44 2% 1.62 2% 0.59 
In a relationship 132 65% 55 63% 77 68% 0.49 
Any children 182 90% 104.92 86% 76.95 95% >0.01 
Always use condoms with 
clients 196 97% 119 98% 76.95 95% 0.35 
Experienced IPV in the 
last year 70 34% 41.48 34% 29.16 36% 0.75 
Used alcohol at last sex 32 16% 18 15% 14 17% 0.15 
Low household income 
(<R5000/month) 
125.86 62% 69.54 57% 55.89 69% 0.1 
Knows other FSWs 
engaging in condomless 
sex 
81.2 40% 45.14 37% 35.64 44% 0.28 
In debt 78 38% 42.7 35% 34.83 43% 0.26 
All income made from sex 
work 174 86% 108 89% 65.61 81% >0.01 
Amount charged to last 
client (ZAR) 103.57 (156.70) 114.75 (188.28) 86.73 (88.92) 0.21 
Money earnt from sex 
work in last week (ZAR) 
1606.45 (1392.34) 1762.54 (1548.29) 1371.36 (1084.49) 0.05 
Average price charged for 
protected sex 
83.06 (90.24) 72.38 (72.98) 99.14 (109.88) 0.04 
Average price charged for 
condomless sex 
411.16 (355.97) 466.52 (385.13) 347.5 (316.84) 0.28 
 
DCE results 
Tables 3 and 4 show results from MNL and MMNL main effects estimation respectively.  Both 
tables show results for the unframed (models 3A and 4A) and PrEP framed (models 3B and 4B) 
DCEs. These tables also show the interaction specification of equation 4 (models 3C and 4C), 
where interaction coefficients represent the difference in preference weights between framings, 
and where a statistically significant parameter indicates that choices under assumed 100%  HIV 
protection differ from those under no protection.  
Results are broadly consistent across MNL and MMNL specifications, and coefficient signs are in 
line with the theoretical expectations in table 1. The non-significant price parameters in the 
unframed models 3A and 4A suggest that FSWs do not choose clients based on price in current 
practice, but condom use, client characteristics and the type of sex are all significantly important 
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factors. However, the significant price parameter in models 3B and 4B suggest that price will 
strongly influence choices after the introduction of PrEP. We test the hypothesis that price will 
become more important with PrEP use by examining the price*PrEP framing parameter in 
models 3C and 4C, which show significance at the 95% level and therefore suggests there is strong 
evidence for an increased influence of price on choices after the introduction of PrEP. 
Additionally, we find that the utility of condom-protected sex is significantly reduced by PrEP use. 
In the MNL model, we find evidence that the framing of tasks was broadly understood due to the 
significant reduction in disutility from a client suspected as being HIV positive. However, this is 
not observed in the MMNL specification suggesting heterogeneity in the effect of framing across 
respondents. Both models suggest that, while FSWs do not favour clients who are perceived to 
have a STI, PrEP does not have a statistically significant effect on the magnitude of this disutility, 
indicating that respondents understand the framing that products only protect against HIV. 
Likewise, in both models, providing anal sex causes significant disutility in current practice and 
the extent of this does not appear to change with the introduction of PrEP. There is no significant 
difference in preferences for any attribute, nor the impact of PrEP, among FSWs using 
contraception and those who are not, indicating that the impact of PrEP framing does not vary by 
pregnancy risk (results available from authors upon request). 
The MMNL displays lower log-likelihood, AIC and BIC values than the MNL, however, these cannot 
be directly compared to assess model performance as the randomness introduced by the MMNL 
will inevitably affect these measures. However, the general consistency across MNL and MMNL 
specifications is reassuring. The differences that do occur are likely to be as a result of 
heterogeneity in preferences among the sample, which is not incorporated by the MNL.  
Results suggest that the price premium for unprotected sex will reduce by 73% under full HIV 
protection, as denoted by the significant condom use and price parameters when interacted with 
framing. When the significance of the change in the ratio of these two parameters is assessed by 
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the delta method, the change in price premium due to protection is also statistically significant 
(p=0.046). 
The MNL model shows some evidence that the overall quantity of sex provided would increase 
under PrEP use, as the opt-out parameter decreases significantly under PrEP framing. The lack of 
statistically significant parameters in the unframed DCE WTA ratios, presented in supplementary 
table S1, may be due to the lack of precision in the price estimate which, in fact, further highlights 
the relative importance of the price attribute under PrEP use.  
We assess the theoretical validity of DCE results by comparing data from HIV negative and 
positive respondents, displayed in supplementary table S2 showing MNL results for the unframed 
DCE by HIV status. The implied condom differential from DCE data is, as predicted theoretically, 
larger among HIV-negative FSWs (ZAR 11,315) than HIV-positive FSWs (ZAR 4,224), though this 
difference is not statistically significant when assessed by the delta method (p=0.3), or by 
examination of the individual parameters in the interactions of model (4).  
Simulations 
Since the condomless sex price premium we observe from revealed preference data without PrEP 
is ZAR 394 (ZAR 466 – ZAR 72), we predict that the premium will fall to ZAR 107. All else equal, 
with this reduced condom differential, PrEP use will lead to an increase in condomless sex by a 
factor of 2.27, compared to before the introduction of PrEP. If the premium were to remain 
constant at ZAR 394, the change in the utility provided by condoms and price indicates that the 
quantity of condomless sex would increase by a factor of 3.2.  
Heterogeneity 
We explore observed heterogeneity in our data though specifying interaction effects with several 
respondent characteristics shown in Table 5. The most important finding here is that the impact 
of PrEP does not vary among FSW subgroups (Model 6C), however these null findings may be due 
to the number of parameters estimated in this model relative to the sample size. Although the 
effect of PrEP is consistent across the sample, there is some heterogeneity in preferences for the 
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DCE attributes. Married FSWs value act price significantly less than their unmarried peers across 
both framings, and there is indicative evidence that recent experience of IPV and knowing other 
FSWs who engage in condomless sex may increase the influence of price under PrEP introduction.  
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Table 3: DCE Results – main effects MNL 
  
Model 3A: No frame 
MNL 
Model 3B: PrEP framed 
MNL Model 3C: Interacted MNL 
  Coeff.  SE Coeff.  SE Coeff.  SE 
Price 0.0004  0.0005 0.0012 *** 0.0004 0.0004  0.0005 
Condom use          
 No condom          
 Condom 4.53 *** 0.24 3.69 *** 0.22 4.53 *** 0.24 
Type of sex          
 Vaginal          
 Anal -2.89 *** 0.18 -2.98 *** 0.17 -2.89 *** 0.18 
Perceived client HIV risk          
 Do not think client has HIV          
 Think client has HIV -0.48 *** 0.14 -0.24 ** 0.13 -0.48 *** 0.14 
Perceived client STI risk          
 Do not think client has STI          
 Think client has STI -0.83 *** 0.16 -0.64 *** 0.15 0.83 *** 0.16 
Opt-out (no services to 
either) 1.46 *** 0.17 1.00 *** 0.14 1.46 *** 0.17 
Interactions          
 PrEP framing x price       0.0008 *** 0.0006 
 PrEP framing x condom use       -0.84 ** 0.33 
 PrEP framing x anal sex       -0.09  0.25 
 PrEP framing x client HIV       0.24 ** 0.20 
 PrEP framing x client STI       0.19  0.22 
 PrEP framing x opt-out       -0.46 ** 0.22 
Model diagnostics          
 Log likelihood -587.31   -701.79   -1289.10   
 AIC 1186.62   1415.58   2602.21   
 BIC 1216.60   1445.58   2670.51   
 N 122   122   244   
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Table 4: DCE Results - main effects MMNL 
  
Model 4A: No framing 
MMNL 
Model 4B: PrEP 
framed MMNL 
Model 4C: Interacted 
MMNL 
  Coeff.  SE Coeff.  SE Coeff.  SE 
Price 0.0002  0.0009 0.003 ** 0.0009 0.0018 *** 0.0006 
Condom use          
 No condom          
 Condom 7.46 *** 0.56 6.34 *** 0.45 6.09 *** 0.33 
Type of sex          
 Vaginal          
 Anal -1.54 *** 0.33 -1.29 *** 0.33 -1.66 ** 0.29 
Perceived client HIV risk          
 Do not think client has HIV          
 Think client has HIV -0.89 *** 0.32 -0.97 *** 0.31 -0.69 ** 0.21 
Perceived client STI risk          
 Do not think client has STI          
 Think client has STI -2.33 *** 0.41 -1.44 *** 0.30 -1.05 *** 0.21 
Opt-out (no services) -1.58 ** 0.46 -1.67 *** 0.40 -0.92 ** 0.25 
Interactions          
 PrEP framing x price       0.0019 ** 0.0007 
 PrEP framing x condom use       -0.86 ** 0.42 
 PrEP framing x anal sex       -0.10  0.35 
 PrEP framing x client HIV       0.32  0.25 
 PrEP framing x client STI       0.33  0.28 
 PrEP framing x opt-out       -0.11  0.30 
Distribution parameters           
 Price  0.0008 *** 0.0003 -0.0005  0.0005 -0.0006 ** 0.0002 
 Condom 0.16  0.17 -0.13  0.12 0.12  0.07 
 Anal -4.00 *** 0.50 -4.85 *** 0.61 -2.08 *** 0.23 
 Think client has HIV 0.01  0.21 0.40 * 0.20 0.09  0.13 
 Think client has STI 1.08 *** 0.25 0.51 ** 0.21 0.01  0.12 
 Opt-out 3.11 *** 0.37 2.58 *** 0.25 2.34 *** 0.16 
 PrEP framing x price       0.0019 ** 0.0007 
 PrEP framing x condom use       -0.86  0.42 
 PrEP framing x anal sex       -0.10  0.35 
 PrEP framing x client HIV       0.32  0.25 
 PrEP framing x client STI       0.33  0.28 
 PrEP framing x opt-out       -0.73 *** 0.15 
Model diagnostics          
 Log likelihood -456.76   -538.05   -1058.664   
 AIC 937.5   1100.1   2165.33   
 BIC 997.4   1160.1   2301.93   
 N 122   122   244   
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Table 5: Heterogeneity in preferences - interaction effects 
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Discussion 
This study is the first to quantitatively consider the impact of PrEP on the economics of sex work. 
We use stated preference methods to estimate the effect of introducing effective HIV prevention 
products on the supply of commercial sex. HIV negative FSW participants completed two identical 
DCEs at the beginning and end of a larger survey, where the first DCE was framed in the context 
of current practice (i.e. without PrEP), and the later DCE framed as if FSWs were using a 100% 
effective HIV prevention product (i.e. with PrEP). Consistent with prior expectations, we found 
that PrEP use increased the influence of price on FSW choices whilst condoms were valued 
significantly less. Results strongly suggest that PrEP use could reduce the condom differential 
(price premium for condomless sex) and increase condomless commercial sex. There was some 
evidence of preference heterogeneity between married and unmarried FSWs, however, our 
results do not suggest that the response to PrEP introduction will vary much across FSWs. We 
find that the price of acts does not play an important part in FSW decisions at present, but is likely 
to significantly impact choices after the introduction of PrEP. Our simulations of choice data 
indicate that the condom differential will reduce by 73% under PrEP use. Moreover, the quantity 
of condomless sex provided by FSWs is predicted to more than double, increasing by a factor of 
2.27 under PrEP use. There are three key reasons why this is an important consideration in the 
PrEP response. It is possible that if condom use falls after introducing PrEP, but FSWs are able 
use PrEP effectively, then the projected increase in condomless sex will not substantively affect 
the HIV epidemic. However, higher levels of condomless sex could increase the transmission of 
STIs which may increase the risk of HIV transmission, thus dampening the benefits of PrEP [45] 
– though theoretical modelling work has shown this may not be important [46]. Additionally, if 
PrEP users are unable to fully adhere to regimens, as observed in some trials, then the impact of 
PrEP may be markedly reduced. To-date, there is mixed evidence of condom substitution from 
PrEP trials and demonstration projects. Some data from oral PrEP trials, largely among MSM 
populations, indicate that self-reported condom use has not changed among PrEP users [47-50]. 
In contrast, a number of MSM studies have detected increased STI rates among PrEP users than 
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non-users, an objective indication of increased levels of condomless sex [51-54]. Mathematical 
modelling work suggests that, if present, condom substitution may substantively reduce the 
impact of partially effective products [55, 56]. Future work is required in this area. 
This study suggests that PrEP could exacerbate the difficulties that FSWs face in negotiating 
condom use with commercial sexual partners, if clients are aware that FSWs are using PrEP. In 
this instance, where FSWs are economically vulnerable, or do not have sufficient negotiating 
power with clients to insist on condom use, PrEP may increase the occurrence of condomless sex. 
We also show that FSWs who increase the supply of unprotected sex with PrEP use are simply 
reacting rationally to exogenous market changes imposed by PrEP programmes, and should not 
face blame or stigma as a result. Instead, the unintended consequences of PrEP introduction 
should be fully considered by programme implementers through collection of reliable data on act 
price and condom use, alongside coercion from clients to provide condomless sex.  
This paper is the first to estimate the effect of new HIV prevention products on the supply of 
condomless commercial sex. These findings are important for HIV prevention programmes 
among FSWs as they suggest that condom use may fall after the introduction of effective PrEP 
products, in part due to the increased importance of act price. Although expected by some [57], 
self-reported condom use among PrEP users has not fallen substantially in trials among MSM, 
FSWs, or general populations [48, 58]. Yet, self-reported condom use data could be substantially 
over-reported, for example a list-randomisation study among FSWs in Senegal showed that 
condom use was overestimated by 20 percentage points.  
There are strong scientific, economic, and human rights arguments for implementing PrEP among 
FSWs as soon as possible [1], and rollout has begun in many countries including South Africa [22]. 
The findings of this study do not reduce the public health imperative to make effective HIV 
prevention products available to FSWs, rather we suggest three things: 1) the unintended 
consequences of PrEP implementation should be explicitly measured  to assess how the incentive 
structure of sex work will change as a result of PrEP introduction; 2) FSWs who may struggle to 
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adhere consistently to PrEP should be identified and supported in their adherence, particularly if 
they are also women who are less able to use condoms consistently; and 3) the impact of PrEP 
provision on client attitudes and demands for protected and condomless sex should be 
monitored, as clients (who already have a strong bargaining position) may place excessive 
pressure on FSWs perceived to be using PrEP to provide condomless sex.  
Importantly, these results indicate that a degree of substitution from condom- to PrEP-protected 
sex is a rational response to the use of an effective HIV prevention product, and more work is 
needed to explore how public health programmes can best support FSWs to protect their own 
sexual and reproductive health.  A promising option is the introduction of multipurpose HIV 
prevention products, co-formulated or co-packaged combinations of HIV, STI, and/or 
contraceptive compounds, which have been estimated to be cost-effective among FSWs in South 
Africa [59]. In addition, PrEP use may increase FSW contact with the health system as women 
collect monthly or three-monthly prescriptions[60]. The South African national guidelines for 
PrEP implementation indicate that syndromic STI screening will be carried out at each visit,  
alongside HIV testing and behavioural sexual risk reduction counselling, whilst a urine pregnancy 
test will be carried out at PrEP initiation [22]. This increased contact with the health system may 
increase overall FSW health in addition to direct benefits from HIV prevention. For example, in 
North America patients receiving antiretroviral therapy have an increased likelihood of being 
screened for cardiovascular disease, hepatitis C infection, and cancer [61]. 
This paper has several limitations. First, we use stated preference data on FSW choices because 
observational revealed preference data from PrEP trials or programmes is not yet available, and 
results may be affected by hypothetical bias, yet the direction in which this bias might impact 
results is not clear. The small amount of information on which FSWs make decisions in this study 
compared to the real world means that the impact of the framing may be overstated, and we 
therefore over-predict behavioural changes. By contrast, the salience of PrEP use in reality (for 
example by taking one tablet every day) may increase the perception of protection to a greater 
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extent than the framing of a choice task, making these results conservative. Reassuringly, 
however, evidence from health focused studies suggests that stated and revealed preferences 
may be closely correlated [29, 30]. Furthermore, at the cost of potential hypothetical bias, we are 
able to avoid endogeneity present in observational studies, as some (e.g. risk averse) FSWs may 
be both more likely to opt-in to PrEP use, and to only provide protected sex. We note that whilst 
we considered ways to make the hypothetical tasks more realistic, for example by having real 
photos or profiles of clients as choice tasks, or when FSWs chose a client in reality showing them 
a hypothetical alternative, these were not practically or ethically possible in the busy, largely 
brothel-based data collection process. During the survey, participants were given physical 
examples of potential prevention products to imagine real-world use.  
Second, the choice task itself assumes that FSWs have a substantial degree of agency over their 
choice of clients which may not be accurate. However, qualitative research during the design of 
this study suggests that the large pool of potential clients in this context makes this a reasonable 
assumption [35], whilst the RDS sample necessarily identified FSWs with some link to peer-
educators who are likely to have higher self-efficacy than FSWs not reached by clinical or peer 
networks. This assumption may not hold for other sex work contexts in South Africa, or beyond. 
Third, the DCE is a simplistic representation of choices in sex work. The description of PrEP use, 
describing a perfectly effective product with no adherence requirements, does not reflect the 
imperfect effectiveness of PrEP. However, this was a pragmatic decision to simplify after 
extensive piloting showed that participants found it difficult to understand frames describing 
imperfect effectiveness or additional protection from STIs. We acknowledge that this may 
overstate that behavioural response to HIV protection and that this is a limitation of this study. 
An improved study design would have shown scenarios with varying levels of efficacy, and 
assessed if condom substitution had a dose-response relationship with the amount of protection 
provided; future work should consider the implications of this on sample-size and participant 
fatigue. It is also unrealistic to assume that FSWs can reliably judge client STI or HIV status. 
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Fourth, HIV status was assessed through participant self-report not objective HIV testing, which 
was not feasible as part of this survey. If present, acceptability bias would likely lead to under-
reporting of HIV positive status, though it is not clear how including HIV positive FSWs in this 
analysis would affect results. Indeed, HIV positive respondents may understate a behavioural 
response to use a prevention product, with condoms chosen more often due to the salient, 
negative consequences of HIV infection. Furthermore, FSWs may not know their HIV positive 
status through a lack, or avoidance, of testing. Since this study implicitly asked respondents to 
make choices according to their perceived HIV status, this study estimates the behavioural 
response to prevention products of FSWs who perceive themselves to be HIV negative, although 
in reality they may not be. Recent work from South Africa found that self-reported HIV status had 
a high (94%) positive predictive value but a low negative predictive value (87%) compared to a 
biomarker test; this underestimate in positive status was largely explained by time since last test, 
suggesting self-reported HIV status correlates well with perceived HIV status. 
Fifth, we do not consider the demand side of the commercial sex market, specifically the impact 
of PrEP use among FSWs on the preferences of clients. If clients know, or perceive FSWs to be 
using PrEP, they could use the reduced risk of HIV acquisition in coercive arguments for 
unprotected sex. Finally, the diverse nature of sex work within South Africa and across sub-
Saharan Africa makes generalisability difficult to assess from this small sample of FSWs. 
Conclusion 
We explored how the introduction of new HIV prevention products might influence the 
economics and supply of condomless commercial sex. By applying stated preference methods in 
the form of a repeated discrete choice experiment, we show that introducing an 100% effective 
HIV prevention product may double the number of condomless acts supplied, and considerably 
reduce (by 73%) the price premium for condomless sex through decreasing the value placed on 
condoms and increasing the utility obtained from act price. These findings have implications for 
the possible impact of PrEP rollout among FSW groups, which is proceeding worldwide, 
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especially in scenarios where women find it hard to effectively adhere to PrEP. In these settings, 
the reduced use of condoms may reduce the impact of PrEP. Further research is needed on the 
revealed preferences of FSWs and clients to assess how PrEP and associated economic incentives 
related to condomless sex affect health choices in commercial sex to allow appropriate support 
interventions to be put in place. 
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Supplementary table S1: Willingness to accept ratios  
  
WTA: No framing 
MMNL 
WTA: PrEP framed 
MMNL 
  Coeff.  SE Coeff.  SE 
Price 1 - - 1 - - 
Condom use       
 Condom*PrEP framing 11721.8  10436.5 3184.3 *** 804.9 
Type of sex       
 Anal*PrEP framing -7529.0  6907.2 -2572.1 *** 709.4 
Perceived client HIV risk       
 Think client has HIV*PrEP framing -1240.4  1117.4 -207.3 ** 87.2 
Perceived client STI risk       
 Think client has STI*PrEP framing -2156.5  2150.7 -549.3 *** 174.1 
Opt-out (no services to either)       
 Opt-out*PrEP framing 3795.5  3135.1 860.6 *** 227.1 
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Supplementary table S2: Comparison of preferences by HIV status 
   (1)   (2)   (3)   (4)  
  Whole sample HIV-positive HIV-negative Interaction model 
  Coeff.  SE Coeff.  SE Coeff.  SE Coeff.  SE 
Price   0.0006 *** 0.0003 0.0008 ** 0.0004 0.0004   0.0005 0.0009 *** 0.0003 
Condom use                 
 No condom                 
 Condom 3.9543 *** 0.1658 3.3788 *** 0.2314 4.5258 *** 0.2434 4.0703 *** 0.1642 
Type of sex                 
 Vaginal                 
 Anal -2.5147  0.1227 -2.1307  0.1708 -2.8913  0.1776 -2.9205  0.1233 
Perceived client HIV risk                 
 
Do not think client has 
HIV                 
 Think client has HIV -0.556  0.1023 -0.652  0.1486 -0.4763  0.1428 -0.339  0.0969 
Perceived client STI risk                 
 
Do not think client has 
STI                 
 Think client has STI -0.6011  0.1094 -0.4142  0.149 -0.8281  0.1639 -0.7116  0.1081 
Opt-out (no services to either) 1.1347 *** 0.1148 0.7174 *** 0.1633 1.4575 *** 0.1659 1.2283 *** 0.1053 
Interactions                 
 HIV positive x price             -0.0001  0.0005 
 
HIV positive x condom 
use             -0.6916  0.2838 
 HIV positive x anal sex             0.7898 ** 0.2106 
 HIV positive x client HIV             -0.3129  0.1774 
 HIV positive x client STI             0.2975 * 0.1841 
 HIV positive x opt-out             -0.511  0.1943 
                  
Implied condom differential 
(ZAR) 
         
6,591    
         
4,224    
         
11,315        
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